Becton Dickinson is positioned to potentially extend its earnings-beat streak when it reports next on November 5, 2026, according to Zacks Investment Research. The medical device manufacturer has beaten estimates in each of its last two quarters, with an average surprise of 3.78%. In its most recent report, Becton Dickinson posted earnings of $3.23 per share against the Zacks Consensus Estimate of $3.14, a surprise of 2.87%, following a prior-quarter result of $2.9 per share versus an expected $2.77, a surprise of 4.69%. The company currently carries an Earnings ESP of +0.21% alongside a Zacks Rank #3 (Hold), a combination that Zacks research shows produces a positive surprise nearly 70% of the time.
Becton Dickinson and CompanyZacks notes Becton Dickinson's positive Earnings ESP and history of beating estimates ahead of its Nov 5, 2026 report.
